Lilly to acquire three vaccine developers for $4 billion
26/05/2026 11:48
May 26 (Reuters) - Eli Lilly LLY.N said on Tuesday it will buy three vaccine developers in deals worth up to nearly $4 billion in combined value, signaling a push by the drugmaker into infectious disease prevention. (Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Eli Lilly and Co
See all newsAntares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
Absci rises on positive hair-loss drug data
China approval for Eli Lilly GLP-1 pill to come as soon as 2026, executive says
HK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)